1939.3000 3.70 (0.19%)
NSE Oct 10, 2025 15:31 PM
Volume: 867.4K
 

1939.30
0.19%
ICICI Securities Limited
Q3FY19 results were in line with I-direct estimates on the operational front. However, net profit was lower mainly due to forex loss Revenues grew 15.9% YoY to | 2555 crore (I-direct estimate: | 2521.0 crore) mainly due to 43.2% growth in Europe to | 321.7 crore (I-direct estimate: | 269.7 crore) and 16.3% growth in the US to | 855.7 crore (I-direct estimate: | 847.9 crore) EBITDA margins improved 237 bps YoY to 17% (in-line with I-direct estimates of 17.4%) mainly due to a 173 bps improvement in gross...
Glenmark Pharmaceuti.. has an average target of 2144.00 from 5 brokers.
More from Glenmark Pharmaceuticals Ltd.
Recommended